{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T23:52:17Z","timestamp":1673394737933},"reference-count":56,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1055\/s-0040-1722171","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T23:35:12Z","timestamp":1611272112000},"page":"109-114","source":"Crossref","is-referenced-by-count":4,"title":["Thrombosis and Haemostasis 2020 Editors' Choice Papers"],"prefix":"10.1055","volume":"121","author":[{"given":"Christian","family":"Weber","sequence":"additional","affiliation":[{"name":"Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany"},{"name":"Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Rigby","sequence":"additional","affiliation":[{"name":"Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-0040-1709650","article-title":"D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis","volume":"120","author":"G Lippi","year":"2020","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0040-1710018","article-title":"COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure","volume":"120","author":"L Spiezia","year":"2020","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1055\/s-0040-1714369","article-title":"Prevalence and impact of coagulation dysfunction in COVID-19 in China: a meta-analysis","volume":"120","author":"S Jin","year":"2020","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1055\/s-0040-1714350","article-title":"Different hypercoagulable profiles in patients with COVID-19 admitted to the internal medicine ward and the intensive care unit","volume":"120","author":"A Boscolo","year":"2020","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1055\/s-0040-1710317","article-title":"Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge","volume":"120","author":"F Violi","year":"2020","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1055\/s-0040-1715836","article-title":"Staging severity of COVID-19 according to hemostatic abnormalities (CAHA score)","volume":"120","author":"B Marchandot","year":"2020","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref7","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1055\/s-0040-1713152","article-title":"Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research","volume":"120","author":"B Bikdeli","year":"2020","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1055\/s-0040-1710019","article-title":"Prevention and treatment of venous thromboembolism associated with coronavirus disease 2019 infection: a consensus statement before guidelines","volume":"120","author":"Z Zhai","year":"2020","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1055\/s-0040-1713167","article-title":"Systematic screening for venous thromboembolic events in COVID-19 pneumonia","volume":"4","author":"G Grandmaison","year":"2020","journal-title":"TH Open"},{"issue":"12","key":"ref10","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1055\/s-0040-1715798","article-title":"Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-European Independent Foundation in Angiology\/Vascular Medicine","volume":"120","author":"G T Gerotziafas","year":"2020","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref11","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1055\/s-0040-1712097","article-title":"Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?","volume":"120","author":"M Cattaneo","year":"2020","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref12","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1055\/s-0040-1713400","article-title":"Role of von Willebrand factor and ADAMTS-13 in the pathogenesis of thrombi in SARS-CoV-2 infection: time to rethink","volume":"120","author":"N Morici","year":"2020","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1055\/s-0040-1715835","article-title":"Mannose-binding lectin is associated with thrombosis and coagulopathy in critically ill COVID-19 patients","volume":"120","author":"O Eriksson","year":"2020","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1055\/s-0040-1714216","article-title":"Obesity and COVID-19: a Virchow's triad for the 21st century","volume":"120","author":"C J Vaughan","year":"2020","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1055\/s-0040-1713678","article-title":"Pathological role of angiotensin II in severe COVID-19","volume":"4","author":"W Miesbach","year":"2020","journal-title":"TH Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1716408","article-title":"The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation","author":"T S Potpara","year":"2020","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1055\/s-0039-1693516","article-title":"Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (Atrial Fibrillation Better Care) pathway for integrated care management: a nationwide cohort study","volume":"119","author":"M Yoon","year":"2019","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1055\/s-0040-1710014","article-title":"Female sex as a risk modifier for stroke risk in atrial fibrillation: using CHA2DS2-VASc versus CHA2DS2-VA for stroke risk stratification in atrial fibrillation: a note of caution","volume":"120","author":"P B Nielsen","year":"2020","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref20","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1055\/s-0039-1683933","article-title":"Incident co-morbidities in patients with atrial fibrillation initially with a CHA2DS2-VASc score of 0 (males) or 1 (females): implications for reassessment of stroke risk in initially \u2018low-risk\u2019 patients","volume":"119","author":"T F Chao","year":"2019","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-0039-3401823","article-title":"Lower versus standard INR targets in atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"120","author":"A K Pandey","year":"2020","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0040-1702230","article-title":"Should we adopt a standard international normalized ratio range of 2.0 to 3.0 for Asian patients with atrial fibrillation? An appeal for evidence-based management, not eminence-based recommendations","volume":"120","author":"T-F Chao","year":"2020","journal-title":"Thromb Haemost"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1718729","article-title":"The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","author":"H K Kim","year":"2020","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1055\/s-0040-1705137","article-title":"Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis","volume":"4","author":"A C Spyropoulos","year":"2020","journal-title":"TH Open"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-0039-1700545","article-title":"Accuracy of a rapid diagnostic test for the presence of direct oral factor Xa or thrombin inhibitors in urine-a multicenter trial","volume":"120","author":"J Harenberg","year":"2020","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref28","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1055\/s-0040-1712914","article-title":"Predicting adverse events beyond stroke and bleeding with the ABC-stroke and ABC-bleeding scores in patients with atrial fibrillation: the Murcia AF project","volume":"120","author":"A Camelo-Castillo","year":"2020","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1055\/s-0039-1696955","article-title":"The use of biomarkers in clinical management guidelines: a critical appraisal","volume":"119","author":"M A Esteve-Pastor","year":"2019","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1055\/s-0040-1705115","article-title":"Antiphosphatidylserine\/prothrombin antibodies: an update on their association with clinical manifestations of antiphospholipid syndrome","volume":"120","author":"M Radin","year":"2020","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-0039-1698460","article-title":"Interpretation and validation of maximum absorbance data obtained from turbidimetry analysis of plasma clots","volume":"120","author":"M Pieters","year":"2020","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-0039-3402055","article-title":"Thrombosis and Haemostasis 2019 Editor's Choice Papers","volume":"120","author":"C Weber","year":"2020","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0039-1695772","article-title":"Effects of edoxaban on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel: results of the EDOX-APT study","volume":"120","author":"F Franchi","year":"2020","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-0040-1702920","article-title":"Platelet inhibition in acute coronary syndrome and percutaneous coronary intervention: insights from the past and present","volume":"120","author":"D A Gorog","year":"2020","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref35","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1055\/s-0040-1713376","article-title":"Dual pathway inhibition for vascular protection in patients with atherosclerotic disease: rationale and review of the evidence","volume":"120","author":"J I Weitz","year":"2020","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref36","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1055\/s-0040-1712098","article-title":"Direct oral anticoagulants for the treatment of acute venous thromboembolism associated with cancer: a systematic review and meta-analysis","volume":"120","author":"M Giustozzi","year":"2020","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1055\/s-0039-3400300","article-title":"Efficacy and safety of nonvitamin K oral anticoagulants in patients with atrial fibrillation and cancer: a study-level meta-analysis","volume":"120","author":"I Cavallari","year":"2020","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1055\/s-0040-1714213","article-title":"The association between oral anticoagulants and cancer incidence among individuals with nonvalvular atrial fibrillation","volume":"120","author":"D Abrahami","year":"2020","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/s-0039-1701009","article-title":"Thromboprophylaxis with rivaroxaban in acutely ill medical patients with renal impairment: insights from the MAGELLAN and MARINER trials","volume":"120","author":"J I Weitz","year":"2020","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0039-1697954","article-title":"NOAC adherence of patients with atrial fibrillation in the real world: dosing frequency matters?","volume":"120","author":"J Hwang","year":"2020","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-0040-1702231","article-title":"The compelling issue of nonvitamin K antagonist oral anticoagulant adherence in atrial fibrillation patients: a systematic need for new strategies","volume":"120","author":"M Proietti","year":"2020","journal-title":"Thromb Haemost"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1718734","article-title":"Patient satisfaction: a key component in increasing treatment adherence and persistence","author":"E Ivany","year":"2020","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1055\/s-0040-1714654","article-title":"Left atrial appendage occlusion: past, present and future","volume":"120","author":"W Y Ding","year":"2020","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1055\/s-0039-1688687","article-title":"Effects and interferences of emicizumab, a humanised bispecific antibody mimicking activated factor VIII cofactor function, on coagulation assays","volume":"119","author":"J I Adamkewicz","year":"2019","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref45","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1055\/s-0039-1692427","article-title":"Laboratory monitoring in emicizumab-treated persons with hemophilia A","volume":"119","author":"J M\u00fcller","year":"2019","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1055\/s-0040-1714279","article-title":"Bridging the missing link with emicizumab: a bispecific antibody for treatment of hemophilia A","volume":"120","author":"G Gelbenegger","year":"2020","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-0039-3401822","article-title":"Cost-effectiveness and budget impact of emicizumab prophylaxis in haemophilia A patients with inhibitors","volume":"120","author":"P A Cortesi","year":"2020","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref48","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0040-1709711","article-title":"Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis","volume":"120","author":"D Pastori","year":"2020","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref49","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0040-1708035","article-title":"Thrombo-inflammation in cardiovascular disease: an expert consensus document from the Third Maastricht Consensus Conference on Thrombosis","volume":"120","author":"E d'Alessandro","year":"2020","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-0039-3400746","article-title":"Interruption of the CXCL13\/CXCR5 chemokine axis enhances plasma IgM levels and attenuates atherosclerosis development","volume":"120","author":"E PC van der Vorst","year":"2020","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-0039-1700871","article-title":"High-content immunophenotyping and hierarchical clustering reveal sources of heterogeneity and new surface markers of human blood monocyte subsets","volume":"120","author":"J Hoffmann","year":"2020","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-0039-3400959","article-title":"Ly6CLo monocyte\/macrophages are essential for thrombus resolution in a murine model of venous thrombosis","volume":"120","author":"A S Kimball","year":"2020","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0039-1701044","article-title":"Myeloid cells to the rescue: improving thrombus resolution","volume":"120","author":"T Knopp","year":"2020","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-0039-3402731","article-title":"Traps N\u2032 clots: NET-mediated thrombosis and related diseases","volume":"120","author":"D Stakos","year":"2020","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1055\/s-0040-1702225","article-title":"Pretransplant genetic susceptibility: clinical relevance in transplant-associated thrombotic microangiopathy","volume":"120","author":"E Gavriilaki","year":"2020","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1055\/s-0040-1702229","article-title":"Plasma protein signatures of a murine venous thrombosis model and Slc44a2 knockout mice using quantitative-targeted proteomics","volume":"120","author":"J Tilburg","year":"2020","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref57","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0040-1702232","article-title":"Novel approaches to unravel risk factors and mechanisms of venous thrombosis","volume":"120","author":"I Scheller","year":"2020","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref58","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1055\/s-0040-1709524","article-title":"Platelet activation via shear stress exposure induces a differing pattern of biomarkers of activation versus biochemical agonists","volume":"120","author":"Y Roka-Moiia","year":"2020","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref59","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0040-1708480","article-title":"Effects of native fucosylated glycosaminoglycan, its depolymerized derivatives on intrinsic factor Xase, coagulation, thrombosis, and hemorrhagic risk","volume":"120","author":"L Zhou","year":"2020","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1722171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T23:39:34Z","timestamp":1611272374000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0040-1722171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":56,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2021,1,21]]},"published-print":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0040-1722171","relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}